Suppr超能文献

禽流感病毒 A(H7N9):从低致病性到高致病性。

Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic.

机构信息

Shenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Third People's Hospital, Shenzhen, 518114, China.

National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.

出版信息

Front Med. 2021 Aug;15(4):507-527. doi: 10.1007/s11684-020-0814-5. Epub 2021 Apr 16.

Abstract

The avian influenza A (H7N9) virus is a zoonotic virus that is closely associated with live poultry markets. It has caused infections in humans in China since 2013. Five waves of the H7N9 influenza epidemic occurred in China between March 2013 and September 2017. H7N9 with low-pathogenicity dominated in the first four waves, whereas highly pathogenic H7N9 influenza emerged in poultry and spread to humans during the fifth wave, causing wide concern. Specialists and officials from China and other countries responded quickly, controlled the epidemic well thus far, and characterized the virus by using new technologies and surveillance tools that were made possible by their preparedness efforts. Here, we review the characteristics of the H7N9 viruses that were identified while controlling the spread of the disease. It was summarized and discussed from the perspectives of molecular epidemiology, clinical features, virulence and pathogenesis, receptor binding, T-cell responses, monoclonal antibody development, vaccine development, and disease burden. These data provide tools for minimizing the future threat of H7N9 and other emerging and re-emerging viruses, such as SARS-CoV-2.

摘要

甲型流感病毒(H7N9)是一种与活禽市场密切相关的动物源性病毒。自 2013 年以来,该病毒已在中国导致人类感染。自 2013 年 3 月至 2017 年 9 月,中国共发生了五波 H7N9 流感疫情。前四波疫情以低致病性 H7N9 为主,而第五波疫情中出现了高致病性 H7N9 流感病毒,在禽类中传播并扩散至人类,引起广泛关注。中国和其他国家的专家和官员迅速做出反应,迄今为止,通过做好准备工作,利用新技术和监测工具,成功控制了疫情。在此,我们从分子流行病学、临床特征、毒力和发病机制、受体结合、T 细胞反应、单克隆抗体开发、疫苗开发和疾病负担等方面,综述了在控制疾病传播过程中鉴定的 H7N9 病毒的特征。对这些数据进行了总结和讨论,为降低 H7N9 及其他新发和再发病毒(如 SARS-CoV-2)的未来威胁提供了工具。

相似文献

1
Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic.
Front Med. 2021 Aug;15(4):507-527. doi: 10.1007/s11684-020-0814-5. Epub 2021 Apr 16.
3
Genesis and Spread of Newly Emerged Highly Pathogenic H7N9 Avian Viruses in Mainland China.
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01277-17. Print 2017 Dec 1.
5
Epidemiology, Evolution, and Pathogenesis of H7N9 Influenza Viruses in Five Epidemic Waves since 2013 in China.
Trends Microbiol. 2017 Sep;25(9):713-728. doi: 10.1016/j.tim.2017.06.008. Epub 2017 Jul 19.
6
The Effects of Genetic Variation on H7N9 Avian Influenza Virus Pathogenicity.
Viruses. 2020 Oct 28;12(11):1220. doi: 10.3390/v12111220.
7
Co-circulation of multiple genotypes of influenza A (H7N9) viruses in eastern China, 2016-2017.
Arch Virol. 2018 Jul;163(7):1779-1793. doi: 10.1007/s00705-018-3800-3. Epub 2018 Mar 14.
8
Effectiveness of Live Poultry Market Interventions on Human Infection with Avian Influenza A(H7N9) Virus, China.
Emerg Infect Dis. 2020 May;26(5):891-901. doi: 10.3201/eid2605.190390. Epub 2020 May 17.
9
Detecting Spread of Avian Influenza A(H7N9) Virus Beyond China.
Emerg Infect Dis. 2015 May;21(5):741-9. doi: 10.3201/eid2105.141756.
10
Preliminary Epidemiology of Human Infections with Highly Pathogenic Avian Influenza A(H7N9) Virus, China, 2017.
Emerg Infect Dis. 2017 Aug;23(8):1355-1359. doi: 10.3201/eid2308.170640. Epub 2017 Aug 15.

引用本文的文献

1
Highly pathogenic avian influenza: pandemic preparedness for a scenario of high lethality with no vaccines.
Front Public Health. 2025 Jul 16;13:1613869. doi: 10.3389/fpubh.2025.1613869. eCollection 2025.
4
Biosafety and immunology: An interdisciplinary field for health priority.
Biosaf Health. 2024 Jul 14;6(5):310-318. doi: 10.1016/j.bsheal.2024.07.005. eCollection 2024 Oct.
5
Preparedness, prevention and control related to zoonotic avian influenza.
EFSA J. 2025 Jan 29;23(1):e9191. doi: 10.2903/j.efsa.2025.9191. eCollection 2025 Jan.
7
Epidemiological characterization of human infection with H5N6 avian influenza.
Front Public Health. 2024 Oct 2;12:1398365. doi: 10.3389/fpubh.2024.1398365. eCollection 2024.
9
Host proteins interact with viral elements and affect the life cycle of highly pathogenic avian influenza A virus H7N9.
Heliyon. 2024 Mar 19;10(7):e28218. doi: 10.1016/j.heliyon.2024.e28218. eCollection 2024 Apr 15.

本文引用的文献

3
Dynamic PB2-E627K substitution of influenza H7N9 virus indicates the in vivo genetic tuning and rapid host adaptation.
Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23807-23814. doi: 10.1073/pnas.2013267117. Epub 2020 Sep 1.
4
Laboratory biosafety in China: past, present, and future.
Biosaf Health. 2019 Sep;1(2):56-58. doi: 10.1016/j.bsheal.2019.10.003. Epub 2019 Oct 31.
5
Severe human infection with a novel avian-origin influenza A(H7N4) virus.
Sci Bull (Beijing). 2018 Aug 30;63(16):1043-1050. doi: 10.1016/j.scib.2018.07.003. Epub 2018 Jul 19.
6
It's not just science: Challenges for public health intervention in Ebola epidemics in the Democratic Republic of Congo.
Sci China Life Sci. 2020 Jul;63(7):1079-1081. doi: 10.1007/s11427-019-1670-6. Epub 2020 Mar 10.
7
Burden of influenza-associated outpatient influenza-like illness consultations in China, 2006-2015: A population-based study.
Influenza Other Respir Viruses. 2020 Mar;14(2):162-172. doi: 10.1111/irv.12711. Epub 2019 Dec 23.
8
Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice.
Cell Host Microbe. 2019 Dec 11;26(6):715-728.e8. doi: 10.1016/j.chom.2019.10.003. Epub 2019 Nov 19.
10
Avian-to-Human Receptor-Binding Adaptation of Avian H7N9 Influenza Virus Hemagglutinin.
Cell Rep. 2019 Nov 19;29(8):2217-2228.e5. doi: 10.1016/j.celrep.2019.10.047.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验